250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 5 Art Startup Investors in Singapore in December 2024

A list of 5 angel investors and VC (Venture Capital) funds that invest in Art startups based in Singapore. We rank investors based on the number of investments they made in Art companies from Singapore. We update this investor list every month.

Top 5 Art Startup Investors in Singapore in December 2024

Investor Art Singapore investments
Antler 2
Susquehanna International Group (SIG) 1
Alameda Research 1
East Ventures 1
iGlobe Partners 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Antler VC Fund · Singapore, Central Region, Singapore · 114 investments in the past 12 months
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Pre-Seed, Seed, Series A
  • Singapore, United Kingdom, Australia
Portfolio highlights
  • Immibot — Get assistance from our AI-powered chatbot on your immigration journey. Our model is trained on official regulations to answer any questions you may have on how to move abroad.
  • Quench.ai — Quench is a tech infrastructure for video creators to deliver exclusive content, engage and reward their true fans.
  • Source — Source is an AI-powered recruitment platform that makes tech talent sourcing fast, precise, and cost-effective.
Susquehanna International Group (SIG) VC Fund · Bala Cynwyd, Pennsylvania, United States · 10 investments in the past 12 months
Discover Susquehanna, a global quantitative trading firm built on a rigorous, analytical foundation in financial markets.
Show more
Investment focus
  • Software, Financial Services, Internet
  • Series A, Series B, Funding Round
  • United States, China, Singapore
Portfolio highlights
  • zkLink — zkLink is a unified middleware layer connecting L1 chains and L2 networks with zk-SNARKs technology, reshaping the crypto landscape for DeFi, NFT, and RWA trading.
  • Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
  • Wakefit — Buy mattress and pillows online at best price. Select from wide range of single, double, king size and queen size mattresses. *100 nights risk free trial *10 year warranty *COD *Free Shipping
Alameda Research VC Fund · Central and Western, Hong Kong Island, Hong Kong · 2 investments in the past 12 months
Alameda Research is a quantitative cryptocurrency trading firm that provides liquidity in cryptocurrency and digital assets markets. It was founded in 2017 and is headquartered in Central and Western, Hong Kong.
Show more
Investment focus
  • Blockchain, Cryptocurrency, Financial Services
  • Seed, Series A, Funding Round
  • United States, Singapore, United Kingdom
Portfolio highlights
  • 3Commas — 3Commas provides a platform for cryptocurrency investors to trade with minimal risks, limit losses, and increase profits. 3Commas was founded in 2017 and is based in Toronto, Ontario.
  • Jito Labs — Jito Labs is a leading Solana MEV Infrastructure Company. We build high-performance systems to maximize the performance of the Solana blockchain and enhance validator rewards. Explore our products like Jito-Solana Client, Jito Block Engine, and Jito Relayer designed for validators. Our solutions like Jito Bundles, Jito Mempool, and ShredStream are tailored for traders and stakers.
  • Optim Finance — Optim Finance provides investment tools that optimize yield on digital assets. Their financial primitives enable users to rent ADA delegation rights to power novel use cases such as SPO loans, leverage into ISOs, and initial bonds.
East Ventures VC Fund · Tokyo, Tokyo, Japan · 53 investments in the past 12 months
East Ventures is an early stage venture capital (VC) focused on Southeast Asia, Indonesia & Japan. Success cases include Tokopedia, Traveloka, and Mercari.
Show more
Investment focus
  • Software, Information Technology, E-Commerce
  • Seed, Series A, Funding Round
  • Japan, Indonesia, Singapore
Portfolio highlights
  • SoLeLands — SoLeLands provides children with future-ready skills, virtues, and applied competences and inspires children to love learning.
  • Maka Motors — MAKA is dedicated to building the best electric motorcycles for Indonesian riders.
  • Zenith Learning Group — Zenith Learning Group's mission is to deliver a holistic, world-class education to learners across South East Asia through technology.
iGlobe Partners VC Fund · Singapore, Central Region, Singapore · 3 investments in the past 12 months
We are a Venture Capital firm based in Singapore with a strong proven track record. We have assisted our companies to successful globalisation and exits over multiple business cycles. Our Funds focus on Smart Cities, FinTech, Digital Media and Extended Reality.
Show more
Investment focus
  • Health Care, Software, Biotechnology
  • Series A, Series B, Series C
  • United States, Singapore, United Kingdom
Portfolio highlights
  • Docquity — Exchange ideas with the best doctors in the region. Receive educational resources designed by well known and respected leaders. Attend virtual discussions
  • Orbital Therapeutics — Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible.
  • Accession Therapeutics — Accession Therapeutics’ elegant Trocept platform has potential to treat some of the most intractable and widespread forms of cancer. Based in Oxford, UK, it is developing a pipeline of products to the early clinical trial stage. Led by Bent Jakobsen, PhD FMedSci, a pioneer of T cell receptor therapy for cancer, the team is highly experienced intaking immuno-oncology products to the clinic. Accession Therapeutics’ Trocept technology is based on over a decade’s work and has generated exceptional preclinical data.Accession Therapeutics’ proprietary technology incorporates cancer-tropic viruses, the first time that viruses have been genetically modified to exclusively target cancer cells. As non-cancerous cells are not targeted by Trocept, systemic toxicity is eliminated meaning the drugs can be delivered intravenously and traffic to the tumour. Trocept’s highly potent and local activity gives it potential in some of the hardest to treat and most widespread forms of cancer. This includes breast, cervical, colorectal, gastric, head and neck, lung, oral, ovarian and pancreatic cancer.
Investors by industry
Investors by country
Investors in Singapore by industry